Literature DB >> 9882569

Molecular characterization, enzymatic analysis, and purification of murine proprotein convertase-1/3 (PC1/PC3) secreted from recombinant baculovirus-infected insect cells.

A Boudreault1, D Gauthier, N Rondeau, D Savaria, N G Seidah, M Chrétien, C Lazure.   

Abstract

A cDNA coding for the murine proprotein convertase-1 (mPC1 also known as mPC3 or mSPC3) was inserted into the Autographa californica nuclear polyhedrosis virus. Following infection of Spodoptera frugiperda cells, the recombinant N-glycosylated protein is secreted into the cell culture medium from which it can be purified to homogeneity as a fully enzymatically active enzyme. Two major secreted molecular forms of mPC1 with apparent molecular weights of 85 and 71 kDa, respectively, and a minor one of 75 kDa are immunodetected in the medium. Automated NH2-terminal sequencing reveals that all three forms result from processing at the predicted zymogen activation site whereas both the 75- and the 71-kDa forms are truncated at their COOH-terminus. Labeling by an active-site titrant demonstrates that the 85-kDa form is optimally labeled at near neutral pH whereas the COOH-truncated forms are optimally labeled at acidic pH. Additionally it is shown that the 85-kDa mPC1 is transformed into the COOH-truncated forms following in vitro incubation at acidic pH levels and in presence of calcium. Concomitantly, the transformation from 85 to 71 kDa is accompanied by a 10- to 40-fold increase in enzymatic activity upon assaying at pH 6.0. The 71-kDa form can be recovered after purification at a level of 1 to 1.5 mg per liter of cell culture medium and is enzymatically stable only in the pH range from 5.0 to 6.5. Cells treated with tunicamycin show a drastically reduced secretion of the convertase in the medium but are not affected by swainsonine and deoxymannojirimycin. Finally, the 85-kDa secreted mPC1 is shown to be sulfated. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9882569     DOI: 10.1006/prep.1998.0964

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.

Authors:  Akihiko Ozawa; Juan R Peinado; Iris Lindberg
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

4.  Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.

Authors:  Ajoy Basak; Claude Lazure
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

5.  A proprotein convertase-inhibiting serpin with an endoplasmic reticulum targeting signal from Branchiostoma lanceolatum, a close relative of vertebrates.

Authors:  Caterina Bentele; Olaf Krüger; Ulf Tödtmann; Mareke Oley; Hermann Ragg
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

6.  Modulation of PC1/3 activity by self-interaction and substrate binding.

Authors:  Akina Hoshino; Dorota Kowalska; François Jean; Claude Lazure; Iris Lindberg
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

Review 7.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

8.  Pax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing.

Authors:  Ting Liu; Yanxia Zhao; Na Tang; Ruopeng Feng; Xiaolong Yang; Nicole Lu; Jinhua Wen; Lingsong Li
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.